Vitamin E for people with non-alcoholic fatty liver disease
Wen H, Deng H, Yang L, et al.
Cochrane Database Syst Rev. Pub. online 16 Oct 2024.
Leggi
Breaking news
Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction
Marx N, Rydén L, Federici M, et al.
Eur Heart J. Pub. online 10 Oct 2024.
Leggi
Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone – a FIDELITY analysis
Pitt B, Agarwal R, Anker SD, et al.
Eur Heart J Cardiovasc Pharmacother. Pub. online 8 Oct 2024.
Leggi
Sleep irregularity and the incidence of type 2 diabetes: a device-based prospective study in adults
Chaput JP, Biswas RK, Ahmadi M, et al.
Diabetes Care. Pub. online 10 Oct 2024.
Leggi
Slowing the progression of diabetic and non-diabetic kidney disease: a summary of the current evidence base for sodium-glucose co-transporter-2 inhibitors
Rotbain Curovic V, Stougaard EB, Hansen TW
Diabetes Obes Metab. Pub. online 15 Oct 2024.
Leggi
Risk of suicidal ideation or attempts in adolescents with obesity treated with glp1 receptor agonists
Kerem L, Stokar J
JAMA Pediatr. 2024 Oct 14
Leggi
Somatic and mental symptoms associated with dysglycaemia, diabetes-related complications and mental conditions in people with diabetes: ssessments in daily life using continuous glucose monitoring and ecological momentary assessment
Hermanns N, Ehrmann D, Kulzer B, et al.
Diabetes Obes Metab. Pub. online 7 Oct 2024.
Leggi
Metformin continuation post-metabolic bariatric surgery and relapse of diabetes
Dicker D, Pinto D, Reges O
Diabetes Obes Metab. Pub. online 9 Oct 2024.
Leggi
Muscle mass and glucagon-like peptide-1 receptor agonists: adaptive or maladaptive response to weight loss?
Linge J, Birkenfeld AL, Neeland IJ
Circulation. Pub. online 15 Oct 2024.
Leggi
The interplay of persistent organic pollutants and mediterranean diet in association with the risk of gestational diabetes mellitus
Yu G, Pang WW, Yang J, et al.
Diabetes Care. Pub. online 9 Oct 2024.
Leggi